“…Sample separation was performed by SDS-PAGE, followed by transfer to a PVDF membrane. The membrane was blocked by 5% skimmed milk solution [ 37 , 91 ]. The following primary antibodies were used: anti-UCP1 (1:750, R&D Systems, Minneapolis, MN, USA, MAB6158), anti-p62 (1:5000, Novus Biologicals, Centennial, CO, USA, NBP1-49956), anti-LC3 (1:2000, Novus Biologicals, NB100-2220), anti-Parkin (1:750, Santa Cruz Biotechnology, Dallas, TX, USA, sc-32282), anti-NBR1 (1:1000, Novus Biologicals, NBP1-71703), and anti-β-actin (1:5000, A2066).…”